Skip to main content

ScienceDex / Researcher record

McCormack, Jennifer

From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.

FY2022 NIH rank #292
  • Top 5% Funded
  • Early Career

NIH Funding · FY2022

$8.8M
Full award amounts, FY2022
6
Records listing this PI
#292
By linked amount among FY2022 PIs
2022
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2022$8,797,7136#292
2023$10,256,43412#223

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY2022 · selected6 records
  2. FY202312 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for McCormack, Jennifer. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2022 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2022 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2022 award records by amount

NIH award records listing McCormack, Jennifer as a PI. Multi-PI records show the full award amount for context.

  • 75N95022D00017-0-759502200001-1N01Contact PI
    NIDA DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT CENTER MANAGEMENT AND SUPPORT. 09/05/2022 - 09/04/2023. N01DA-22-2253. TASK ORDER 75N95022F00001 (TO
    $2.3M
    award amount
  • 75N95022D00017-0-759502200002-1N01Contact PI
    INTEGRATED CARE AND TREATMENT FOR SEVERE INFECTIOUS DISEASES AND SUBSTANCE USE DISORDERS (SUD) AMONG HOSPITALIZED PATIENTS (CTN-0121). 09/28/2022 - 02
    $1.4M
    award amount
  • 75N95022D00017-0-759502200004-1N01Contact PI
    KETAMINE FOR METHAMPHETAMINE USE DISORDER STUDY (CTN-0132). 09/28/2022 - 08/21/2025. DSC6. 75N95022F00004 (TO4).
    $1.4M
    award amount
  • 75N95019D00013-0-759502200001-1N01Contact PI
    NIDA DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT CENTER MANAGEMENT AND SUPPORT. 03/01/2022 - 02/28/2023. N01DA-19-2250. TASK ORDER 75N95022F00001 (TO
    $1.4M
    award amount
  • 75N95019D00013-0-759502200002-1N01Contact PI
    MANAGEMENT OF UNHEALTHY OPIOID AND POLYSUBSTANCE USE AMONG PATIENTS IN PRIMARY CARE SETTING. 09/01/2022 - 08/14/2027. N01DA-19-2250. TASK ORDER 75N950
    $1.2M
    award amount
  • 75N95022D00017-0-759502200003-1N01Contact PI
    OFFICE-BASED METHADONE VS BUPRENORPHINE TO ADDRESS RETENTION IN MEDICATION FOR OPIOID USE DISORDER (MOUD)-A PRAGMATIC HYBRID EFFECTIVENESS/IMPLEMENTAT
    $1M
    award amount

Award organization

Organizations that administered FY2022 awards listing McCormack, Jennifer as a PI.

FY2022 award administered by The Emmes Company, LLC (MD).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2022
    First NIH Award
    The Emmes Company, LLC
  2. 2022
    $500K Cumulative Funding
  3. 2022
    $1M Cumulative Funding
  4. 2022
    $2M Cumulative Funding
  5. 2022
    $5M Cumulative Funding
  6. 2022
    Entered Top 50% Nationally
    Ranked #292
  7. 2022
    Entered Top 25% Nationally
    Ranked #292
  8. 2022
    Entered Top 10% Nationally
    Ranked #292
  9. 2022
    Entered Top 5% Nationally
    Ranked #292
  10. 2023
    $10M Cumulative Funding